<DOC>
	<DOCNO>NCT00197171</DOCNO>
	<brief_summary>To evaluate persistence immune response 5 year 6 year first vaccine dose .</brief_summary>
	<brief_title>Long Term F/U Studies Y5 &amp; 6 Demonstrate Equivalence 2 Vaccination Schedules Combined Hepatitis A &amp; B Vaccine</brief_title>
	<detailed_description>Open , randomise , long-term antibody persistence study , conduct 2 center . Immune persistence compare subject receive two dos GSK Biologicals combine hepatitis A hepatitis B vaccine either 0 , 6 month schedule 0 , 12 month schedule . These long-term follow-up study involve take blood sample approximately 5 6 year primary vaccination combine hepatitis A B vaccine , ass antibody persistence retrospective safety follow-up .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects receive GSK Biologicals ' combine hepatitis A B vaccine primary study ( HAB082 ) . Subjects age 12 15 year time first vaccination .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>